Spots Global Cancer Trial Database for ybritumomab tiuxetan (zevalin); rituximab; beam (bcnu, arac, vp16 and melphalan)
Every month we try and update this database with for ybritumomab tiuxetan (zevalin); rituximab; beam (bcnu, arac, vp16 and melphalan) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Transplantation With Ybritumomab Tiuxetan (Zevalin) Plus BEAM Regimen in Patients With Refractory Large B-cell Difusse Lymphom | NCT00646750 | Non-Hodgkin's L... | Ybritumomab Tiu... | 18 Years - 70 Years | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | |
| Transplantation With Ybritumomab Tiuxetan (Zevalin) Plus BEAM Regimen in Patients With Refractory Large B-cell Difusse Lymphom | NCT00646750 | Non-Hodgkin's L... | Ybritumomab Tiu... | 18 Years - 70 Years | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
